Rosetta Genomics Overview

  • Founded
  • 2000
Founded
  • Status
  • Public
  • Employees
  • 86
Employees
  • Stock Symbol
  • ROSGQ
Stock Symbol
  • Investments
  • 2

Rosetta Genomics General Information

Description

Rosetta Genomics Ltd is an Israel based genomic diagnostics company operating globally. It is focused on research and development on diagnostics and therapeutics in the field of microRNAs. The firm markets and sells four diagnostic tests based on its microRNA technologies namely, RosettaGX Cancer Origin for the identification of the primary site of metastatic cancer, mi-LUNG, mi-KIDNEY which is a microRNA-based kidney tumor classification test for pathology samples and RosettaGx Reveal which is a microRNA-based assay for the diagnosis of indeterminate thyroid fine-needle aspirate samples. Its revenues include Clinical testing revenues and Licensing revenues, of which Clinical testing revenue is maximum. The group generates its revenues mainly from diagnosing patient tissue.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Therapeutic Devices
Diagnostic Equipment
Stock Exchange
PINX
Primary Office
  • 10 Plaut Street
  • Rehovot 76706
  • Israel
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Rosetta Genomics Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
18.5K

Rosetta Genomics Financials Summary

In Thousands,
USD
TTM 30-Jun-2017 FY 2016 31-Dec-2016 FY 2015 31-Dec-2015 FY 2014 31-Dec-2014
EV 3,714 3,935 11,873 16,326
Revenue 5,827 9,234 8,268 1,327
EBITDA (12,479) (15,330) (16,576) (14,284)
Net Income (13,390) (16,233) (17,345) (14,526)
Total Assets 6,207 11,961 22,423 17,278
Total Debt 2,449 3,795 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Rosetta Genomics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Rosetta Genomics‘s full profile, request access.

Request a free trial

Rosetta Genomics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Rosetta Genomics Ltd is an Israel based genomic diagnostics company operating globally. It is focused on research and de
Pharmaceuticals
Rehovot, Israel
86 As of 2016
00000
000000000000 00000

00000000

citation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehend
0000000000 000000000
South San Francisco, CA
000 As of 0000
00000
000000 - 000 00000

000000 0

adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad mini
0000000000000
Codolet, France
000 As of 0000
0000 0000-00-00
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Rosetta Genomics Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Veracyte Formerly VC-backed South San Francisco, CA 000 00000 000000 - 000 00000
000000 000000000 Formerly PE-Backed Codolet, France 000 000000&0
00000000 Formerly VC-backed Austin, TX 000 000.00 000000&0 000.00
00000 0000000 Corporation Basel, Switzerland 000000 00.000 000000000 00.000
000000000000 Private Equity-Backed Puteaux, France 000 000.00 000000000000
You’re viewing 5 of 10 competitors. Get the full list »

Rosetta Genomics Patents

Rosetta Genomics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2945531-C Mirna expression signature in the classification of thyroid tumors Active 13-May-2014 0000000000
CA-2945531-A1 Mirna expression signature in the classification of thyroid tumors Granted 13-May-2014 0000000000
JP-6216470-B2 Mirna expression signatures in the classification of thyroid tumors Active 13-May-2014 0000000000
JP-2017521051-A Mirna expression signatures in the classification of thyroid tumors Granted 13-May-2014 0000000000
US-20170356055-A1 Mirna expression signature in the classification of thyroid tumors Abandoned 13-May-2014 C12Q1/6886

Rosetta Genomics Executive Team (18)

Name Title Board Seat Contact Info
Ron Kalfus Chief Financial Officer, Finance
Sigal Russo-Gueta Controller
Hila Benjamin Director, Computational Biology
Adriana Folberg-Blum Director of IP and Licensing
Kevin Watson Director, Reimbursement and Managed Care
You’re viewing 5 of 18 executive team members. Get the full list »

Rosetta Genomics Board Members (13)

Name Representing Role Since
Brian Markison Self Chairman & Board Member 000 0000
David Sidransky Ph.D Self Board Member 000 0000
Gerald Dogon Rosetta Genomics Board Member 000 0000
Joshua Rosensweig JD Rosetta Genomics Board Member 000 0000
Roy Davis Self Board Member 000 0000
You’re viewing 5 of 13 board members. Get the full list »

Rosetta Genomics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Rosetta Genomics Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 14-Apr-2015 000000000000000000 00.00 Laboratory Services (Healthcare) 0000000 000000 00
Parkway Clinical Laboratories 24-Jul-2008 Merger/Acquisition 00.00 Laboratory Services (Healthcare)
To view Rosetta Genomics’s complete acquisitions history, request access »

Rosetta Genomics Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000 14-Apr-2015 000000000000000000 00.00 Completed
  • 0000000 00000000
Parkway Clinical Laboratories 24-Jul-2008 Merger/Acquisition 00.00 Completed
To view Rosetta Genomics’s complete exits history, request access »